Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1

Conditions

Mycoses 3Hematologic Neoplasms 3Leukemia 2Invasive Fungal Infections 2Infections 2Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Immunologic Deficiency Syndromes 1

Interventions

Cytarabine 68Cyclophosphamide 44Methotrexate 41Daunorubicin 38Etoposide 34Vincristine 30Mercaptopurine 28Dexamethasone 24Radiotherapy 22Idarubicin 22Asparaginase 21Thioguanine 20Doxorubicin 19Prednisone 17Peripheral Blood Stem Cell Transplantation 17Imatinib Mesylate 16Busulfan 16pegaspargase 15Mitoxantrone 15Filgrastim 13Leucovorin 11fludarabine phosphate 10Hydrocortisone 10nilotinib 9Tretinoin 8Prednisolone 8Cyclosporine 8Hydroxyurea 7Epoetin Alfa 7Azacitidine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Leukemia × Voriconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00904995 2012-08-07

Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

M.D. Anderson Cancer Center

Phase 3 Completed
23 enrolled 4 charts
Other hematologic neoplasm

Invasive Fungal Infections, Leukemia, Mycoses, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡